Anzeige
❌
Mehr »
Freitag, 20.11.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
XB

WKN: A41X7J | ISIN: US98386D4060 | Ticker: HHB0
Stuttgart
20.11.26 | 15:16
1,150 Euro
-2,54 % -0,030
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
XTL BIOPHARMACEUTICALS LTD ADR Chart 1 Jahr
5-Tage-Chart
XTL BIOPHARMACEUTICALS LTD ADR 5-Tage-Chart
RealtimeGeldBriefZeit
0,9901,60017:03

Aktuelle News zur XTL BIOPHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiXTL BioPharmaceuticals GAAP EPS of $0.001
MiXTL BIOPHARMACEUTICALS LTD - 6-K, Report of foreign issuer-
14.10.XTL BIOPHARMACEUTICALS LTD - 6-K, Report of foreign issuer1
21.07.XTL BIOPHARMACEUTICALS LTD - 6-K, Report of foreign issuer1
30.06.XTL BIOPHARMACEUTICALS LTD - 20-F, Annual and transition report of foreign private issuers1
30.06.XTL Biopharmaceuticals Ltd.: XTL Completed the Acquisition of Psyga Bio Ltd.627expands its IP portfolio to clinical-stage biopharmaceutical assets XTL Biopharmaceuticals (XTL) Completes the Acquisition of Psyga Bio and Establishes Psychedelic Biotechnology Platform At a historic...
► Artikel lesen
30.06.XTL BIOPHARMACEUTICALS LTD - 6-K, Report of foreign issuer1
XTL BIOPHARMACEUTICALS Aktie jetzt für 0€ handeln
23.06.XTL BIOPHARMACEUTICALS LTD - 6-K, Report of foreign issuer-
22.05.XTL Biopharmaceuticals Ltd.: XTL Announces Receipt of Staff Delist Determination from Nasdaq341RAMAT GAN, ISRAEL, May 22, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the "Company" or "XTL"), announced today that it has received a letter (the "Letter")...
► Artikel lesen
25.03.XFRA HHB0: WIEDERAUFNAHME/RESUMPTION467FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME...
► Artikel lesen
25.03.XFRA HHB0: AUSSETZUNG/SUSPENSION348DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILXTL BIOPHARMA. ADR...
► Artikel lesen
25.03.XFRA NEW INSTRUMENTS AVAILABLE ON 25.03.2026781The following instruments on XETRA do have their first trading 25.03.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 25.03.2026 Aktien 1 SE0006256558 Absolent Air Care Group...
► Artikel lesen
24.03.XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 24.03.20261.330The following instruments on Boerse Frankfurt do have their last trading day on 24.03.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 24.03.2026.ISIN NameCA4013392051 GUARDIAN...
► Artikel lesen
24.03.XFRA ISIN CHANGE651Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenUS68237Q2030 Onconetix Inc. 24.03.2026 US68237Q3020 Onconetix Inc. 25.03.2026 Tausch 5:1US98386D3070 XTL Biopharmaceuticals...
► Artikel lesen
20.03.XTL Biopharmaceuticals Ltd.: XTL Biopharmaceuticals Announces ADS Ratio Change410RAMAT GAN, ISRAEL, March 20, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the "Company" or "XTL"), announced today that it plans to change the ratio of its American...
► Artikel lesen
10.03.Beyond Air Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd.811GARDEN CITY, N.Y., March 10, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial stage medical device and biopharmaceutical company focused on harnessing...
► Artikel lesen
27.02.XTL Biopharmaceuticals Ltd.: XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing1.021RAMAT GAN, ISRAEL, Feb. 27, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the "Company" or "XTL"), announced today that it has received a letter (the "Letter")...
► Artikel lesen
29.01.XTL Biopharmaceuticals Ltd.: XTL Update on Recent Developments352RAMAT GAN, ISRAEL, Jan. 29, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the "Company" or "XTL"), announced that it is working diligently to close the acquisition...
► Artikel lesen
23.01.XTL Biopharmaceuticals Ltd.: XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency816RAMAT GAN, ISRAEL, Jan. 23, 2026 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the "Company" or "XTL"), announced today that it has received a notification letter from...
► Artikel lesen
13.01.XTL Biopharmaceuticals Ltd.: XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership337Unmatched scientific firepower: Two Nobel Laureates join Founder Prof. Haitham Amal, leading global autism researcher Critical unmet need: 1 in 31 U.S. children now affected, zero FDA-approved disease-modifying...
► Artikel lesen
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1